Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:NDRA OTCMKTS:UMGP NASDAQ:XAGE OTCMKTS:YBGJ On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeNDRAENDRA Life Sciences$4.12+0.2%$5.16$2.90▼$22.68$3.10M-0.18688,099 shs15,009 shsUMGPDalton Industries$0.03+15.5%$0.03$0.02▼$0.16$1.07M0.1327,693 shs34,000 shsXAGELongevity Health$2.60-4.8%$3.03$2.15▼$38.10$4.63M0.51997,772 shs5,931 shsYBGJYubo International Biotech$0.04+11.0%$0.06$0.02▼$0.54$4.24M3.74115,308 shs40,000 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceNDRAENDRA Life Sciences+0.49%-9.27%-35.28%+27.24%-76.93%UMGPDalton Industries+14.09%+14.09%-12.24%-3.83%-72.11%XAGELongevity Health-1.09%+8.33%-30.18%+272,999,900.00%+272,999,900.00%YBGJYubo International Biotech+29.15%+22.69%-29.11%-52.39%-89.72%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationNDRAENDRA Life Sciences2.9237 of 5 stars3.54.00.00.03.80.00.6UMGPDalton IndustriesN/AN/AN/AN/AN/AN/AN/AN/AXAGELongevity HealthN/AN/AN/AN/AN/AN/AN/AN/AYBGJYubo International BiotechN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceNDRAENDRA Life Sciences 3.00Buy$50.001,113.59% UpsideUMGPDalton Industries 0.00N/AN/AN/AXAGELongevity Health 0.00N/AN/AN/AYBGJYubo International Biotech 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookNDRAENDRA Life SciencesN/AN/AN/AN/A$1.96 per shareN/AUMGPDalton Industries$30K35.57N/AN/AN/A∞XAGELongevity Health$1.05M4.40N/AN/A($2.10) per share-1.24YBGJYubo International BiotechN/AN/AN/AN/A($0.02) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateNDRAENDRA Life Sciences-$11.51M-$33.89N/AN/AN/AN/A-194.14%-127.89%N/AUMGPDalton Industries-$260K-$0.01N/A∞N/AN/AN/AN/AN/AXAGELongevity Health-$10.37MN/A0.00∞N/A-682.67%N/A-261.90%N/AYBGJYubo International Biotech-$1.77M-$0.01N/A∞N/AN/AN/A-118.36%N/ALatest UMGP, NDRA, YBGJ, and XAGE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025NDRAENDRA Life Sciences-$2.27-$1.71+$0.56-$1.71N/AN/A8/14/2025Q2 2025XAGELongevity HealthN/A-$1.56N/A-$1.56N/A$0.50 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthNDRAENDRA Life SciencesN/AN/AN/AN/AN/AUMGPDalton IndustriesN/AN/AN/AN/AN/AXAGELongevity HealthN/AN/AN/AN/AN/AYBGJYubo International BiotechN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioNDRAENDRA Life SciencesN/A3.213.21UMGPDalton IndustriesN/AN/AN/AXAGELongevity HealthN/A0.470.30YBGJYubo International BiotechN/A0.130.12Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipNDRAENDRA Life Sciences1.19%UMGPDalton IndustriesN/AXAGELongevity Health24.22%YBGJYubo International BiotechN/AInsider OwnershipCompanyInsider OwnershipNDRAENDRA Life Sciences0.04%UMGPDalton IndustriesN/AXAGELongevity Health29.00%YBGJYubo International Biotech68.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableNDRAENDRA Life Sciences20753,000753,000Not OptionableUMGPDalton Industries2436.80 millionN/ANot OptionableXAGELongevity Health141.78 million1.27 millionN/AYBGJYubo International Biotech20119.82 million53.68 millionNot OptionableUMGP, NDRA, YBGJ, and XAGE HeadlinesRecent News About These CompaniesYubo International Biotech Limited (YBGJ)March 21, 2025 | finance.yahoo.comYubo International Biotech LimitedNovember 21, 2024 | investing.comYBGJ Yubo International Biotech LimitedMay 24, 2024 | seekingalpha.comForever Cheer picks Hong Kong as gateway for global launch of pain management drugs with an eye on US$88.2 billion marketJanuary 3, 2024 | scmp.comPromontory Therapeutics Selected as the First International Biotech Company Member of the Paris-Saclay Cancer ClusterOctober 1, 2023 | finance.yahoo.comSABAH OFFERS TREASURE TROVE OF GENETIC RESOURCES FOR BIOTECH - MINISTERSeptember 10, 2023 | bernama.comBAs biotech conference arrives in Boston, Wu launches push to diversify industryJuly 6, 2023 | wgbh.orgWYubo International Biotech Ltd.June 15, 2023 | wsj.comChemical Engineering (Biotechnology) MEApril 20, 2023 | buffalo.eduBBiotechnology – A Solution to Hunger?February 12, 2023 | un.orgUCovid-19: Bharat Biotech to launch intranasal vaccine on January 26January 23, 2023 | scroll.inSGLOBAL TOTAL REWARDS AND INTERNATIONAL MOBILITY HEADDecember 25, 2022 | mypharma-editions.comMBiology newsSeptember 14, 2022 | phys.orgPBiotechnology Act to Crash Cost of Vaccines, Drugs Import, Drive ResearchSeptember 12, 2022 | thisdaylive.comTYubo International (OTC:YBGJ), Earnings Estimates, EPS, and RevenueJuly 18, 2022 | benzinga.comYubo International (OTC:YBGJ), Analyst Ratings, Price Targets, PredictionsJuly 18, 2022 | benzinga.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeUMGP, NDRA, YBGJ, and XAGE Company DescriptionsENDRA Life Sciences NASDAQ:NDRA$4.12 +0.01 (+0.24%) As of 03:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.Dalton Industries OTCMKTS:UMGP$0.03 +0.00 (+15.54%) As of 02:24 PM EasternUniversal Media Group Inc., a media company, produces and distributes media content worldwide. It produces On The Mike, a TV show that primarily include celebrity interviews, music concerts, and other events. The company was formerly known as Dalton Industries Inc. and changed its name to Universal Media Group Inc. in January 2016. Universal Media Group Inc. was founded in 1971 and is based in Boca Raton, Florida.Longevity Health NASDAQ:XAGE$2.60 -0.13 (-4.76%) As of 03:05 PM EasternCarmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.Yubo International Biotech OTCMKTS:YBGJ$0.04 +0.00 (+10.97%) As of 10:12 AM EasternYubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CrowdStrike at a Crossroads: AI Halo vs. Risks NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It NIO Just Got Its Second Upgrade of the Month, and It’s Big As Bitcoin Falls and Ethereum Rallies, Coinbase Stock Comes Back Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Quality Okta: Market Comes to a Boil, Explosive Upside Is Possible MongoDB Roars Back to Life: It’s Not Too Late to Buy More Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access